Company Filing History:
1 out of 402 
1 out of 587 
1 out of 282 
Years Active: 2019
Title: Abdelsattar Mansour Ebid Omar: Innovator in Therapeutic Agents for Sickle Cell Disease
Introduction
Abdelsattar Mansour Ebid Omar is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of sickle cell disease. His innovative work has the potential to impact many lives suffering from this condition.
Latest Patents
Abdelsattar holds a patent for "Azolylacryloyl derivatives as therapeutic agents for sickle cell disease." This patent describes azolylacryloyl derivatives with hypoxic properties that are suitable for treating sickle cell disease and other hypoxia-related conditions. The compounds have a generic formula and can be used in various medical emergencies, including hemorrhagic and traumatic shock, cardiac arrest, traumatic brain injury, cancer, stroke, myocardial infarction, myocardial ischemia, and vaso-occlusive crisis.
Career Highlights
Throughout his career, Abdelsattar has worked with esteemed institutions such as Virginia Commonwealth University and King Abdulaziz University. His experience in these organizations has allowed him to develop his research and contribute to advancements in medical science.
Collaborations
Abdelsattar has collaborated with notable colleagues, including Martin K. Safo and Yan Zhang. These partnerships have enriched his research and expanded the scope of his work in therapeutic innovations.
Conclusion
Abdelsattar Mansour Ebid Omar is a pioneering inventor whose work in therapeutic agents for sickle cell disease showcases his commitment to improving healthcare. His contributions are vital in addressing serious medical conditions and enhancing patient outcomes.